P & G Health Ltd

{
  "main_header": {
    "sid": 346859,
    "name": "P & G Health Ltd",
    "stock_name": "P & G Health Ltd",
    "full_name": "Procter & Gamble Health Ltd",
    "name_url": "stocks-analysis/p-g-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "4,965.00",
    "chg": 159.7,
    "chgp": "3.32%",
    "dir": 1,
    "prev_price": "4,805.30",
    "mcapval": "8,034.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 500126,
    "symbol": "PGHL",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE199A01012",
    "curr_date": "Apr 10",
    "curr_time": "",
    "bse_nse_vol": "52.79 k",
    "exc_status": "Active",
    "traded_date": "Apr 10, 2026",
    "traded_date_str": "2026 04 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/p-g-health-346859-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3934308",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ProcterGambleHe_mojoScore_3934308.png",
        "date": "2026-04-06 10:10:03",
        "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs46997-3933912",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ProcterGambleHe_priceRelatedfactors_3933912.png",
        "date": "2026-04-06 09:36:52",
        "description": "While broader indices showed resilience, Procter & Gamble Health Ltd slipped to a fresh 52-week low of Rs 4,699.7 on 6 Apr 2026, marking a notable divergence from market trends and raising questions about the underlying factors driving this decline."
      },
      {
        "title": "Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs472505-3929872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ProcterGambleHe_priceRelatedfactors_3929872.png",
        "date": "2026-04-02 09:39:17",
        "description": "Despite a broader market rebound, Procter & Gamble Health Ltd has slipped to a fresh 52-week low of Rs 4,725.05 on 2 Apr 2026, marking a notable divergence from sector and benchmark trends."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3917972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_mojoScore_3917972.png",
        "date": "2026-03-26 10:10:02",
        "description": "Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs-4740-3893491",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3893491.png",
        "date": "2026-03-16 10:32:24",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3892236",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_mojoScore_3892236.png",
        "date": "2026-03-15 10:10:02",
        "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4781",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-stock-falls-to-52-week-low-of-rs4781-3879906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3879906.png",
        "date": "2026-03-09 12:02:34",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low today, with its stock price touching Rs.4781. This marks a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Procter & Gamble Health Ltd Falls to 52-Week Low of Rs.4824.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/procter-gamble-health-ltd-falls-to-52-week-low-of-rs482405-3873590",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_priceRelatedfactors_3873590.png",
        "date": "2026-03-05 12:22:54",
        "description": "Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4824.05, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns."
      },
      {
        "title": "Procter & Gamble Health Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/procter-gamble-health-ltd-is-rated-sell-3869058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/ProcterGambleHe_mojoScore_3869058.png",
        "date": "2026-03-04 10:10:02",
        "description": "Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 March 2026, providing investors with the latest perspective on the company’s position."
      }
    ],
    "total": 148,
    "sid": "346859",
    "stock_news_url": "https://www.marketsmojo.com/news/procter-gamble-health-346859"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Dear Sir/Madam Please find attached disclosure under regulation 74(5) of the SEBI (DP) Regulations for the quarter ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "06-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Procter & Gamble Health Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1967PLC013726</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: ZEAL RUPANI <br/> Designation: Company Secretary <br/> EmailId: SHAH.ZS@PG.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SHASHANK SROWTHY <br/> Designation: CFO Director <br/> EmailId: srowthy.sr@pg.com</div> </div> <div> <br/> Date: 06/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
      "datetime": "27-Mar-2026",
      "details": "Procter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on May 26 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "26 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Procter & Gamble Health Ltd has declared <strong>1100%</strong> dividend, ex-date: 12 Feb 26",
          "dt": "2026-02-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Procter & Gamble Health Ltd is Rated Sell

2026-04-06 10:10:03

Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-06 09:36:52

While broader indices showed resilience, Procter & Gamble Health Ltd slipped to a fresh 52-week low of Rs 4,699.7 on 6 Apr 2026, marking a notable divergence from market trends and raising questions about the underlying factors driving this decline.

Read full news article

Markets Rally, But Procter & Gamble Health Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-02 09:39:17

Despite a broader market rebound, Procter & Gamble Health Ltd has slipped to a fresh 52-week low of Rs 4,725.05 on 2 Apr 2026, marking a notable divergence from sector and benchmark trends.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-03-26 10:10:02

Procter & Gamble Health Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs 4740

2026-03-16 10:32:24

Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4740, marking a significant decline amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-03-15 10:10:02

Procter & Gamble Health Ltd is rated Sell by MarketsMOJO, with this rating last updated on 07 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Procter & Gamble Health Ltd Stock Falls to 52-Week Low of Rs.4781

2026-03-09 12:02:34

Procter & Gamble Health Ltd has reached a new 52-week low today, with its stock price touching Rs.4781. This marks a significant decline amid broader market weakness and ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Read full news article

Procter & Gamble Health Ltd Falls to 52-Week Low of Rs.4824.05

2026-03-05 12:22:54

Procter & Gamble Health Ltd has reached a new 52-week low of Rs.4824.05, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock has underperformed its sector and key indices, reflecting a combination of subdued financial results and valuation concerns.

Read full news article

Procter & Gamble Health Ltd is Rated Sell

2026-03-04 10:10:02

Procter & Gamble Health Ltd is rated Sell by MarketsMOJO. This rating was last updated on 07 Jan 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 04 March 2026, providing investors with the latest perspective on the company’s position.

Read full news article

View All News